Press releases

2007

Topic

13 December	Synosia Therapeutics Announces Appointment of Chief Business Officer

05 November	Synosia Therapeutics Announces Appointment of Vice President of Clinical Research and Development

15 October	Synosia Therapeutics Establishes Scientific Advisory Board

18 June	Synosia Therapeutics Announces Appointment of Vice President of Regulatory Affairs

22 May	New Agreement Boosts Pipeline for Synosia Therapeutics
	Neue Vereinbarung stärkt Pipeline für Synosia Therapeutics

16 May	Synosia Therapeutics Announces Appointment of Chief Medical Officer

23 April	Synosia Therapeutics Announces Second Major Pharmaceutical Deal
	Synosia Therapeutics gibt zweites grosses Pharma-Abkommen bekannt

23 March	Synosis Therapeutics Changes Name to Synosia Therapeutics

04 January	Roche and Synosis Therapeutics announce partnership to explore potential of five compounds targeting the central nervous system
	Roche und Synosis Therapeutics geben ihre Partnerschaft bei der Erforschung des Potenzials von fünf Präparaten, die auf das zentrale Nervensystem abzielen, bekannt

Media Enquiries

Julie Walters
Tudor Reilly (Europe)
Tel: +44 (0) 1494 687860
Mobile: +44 (0) 775 3626967
Email: julie.walters@tudor-reilly.com

Michele Parisi
Tudor Reilly (US)
Tel: +1 925 864 5028
Email: michele.parisi@tudor-reilly.com

Download Company Brochure PDF
Get the fast facts on Synosia

EMAIL REGISTRATION
Sign up for regular updates
on Synosia.

Synosia Therapeutics adopts a privacy policy and will not disclose your email address or details to any third party.

Action you wish to take:

Your email address: